Are Biologics for COPD Around the Corner? A Quick Look at the Literature

Omalizumab, a monoclonal antibody, became the first biologic therapy for severe asthma when it received FDA approval in 2003. Since then, several other biologic therapies have become available for asthma treatment. No biologic therapy is currently approved for chronic obstructive pulmonary disease (COPD), but progress is being made.

Key developments of the past few years are summarized in the slides below.